324 related articles for article (PubMed ID: 23747245)
21. Resident macrophages mediate islet amyloid polypeptide-induced islet IL-1β production and β-cell dysfunction.
Westwell-Roper CY; Ehses JA; Verchere CB
Diabetes; 2014 May; 63(5):1698-711. PubMed ID: 24222351
[TBL] [Abstract][Full Text] [Related]
22. LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus.
Cobo-Vuilleumier N; Lorenzo PI; Rodríguez NG; Herrera Gómez IG; Fuente-Martin E; López-Noriega L; Mellado-Gil JM; Romero-Zerbo SY; Baquié M; Lachaud CC; Stifter K; Perdomo G; Bugliani M; De Tata V; Bosco D; Parnaud G; Pozo D; Hmadcha A; Florido JP; Toscano MG; de Haan P; Schoonjans K; Sánchez Palazón L; Marchetti P; Schirmbeck R; Martín-Montalvo A; Meda P; Soria B; Bermúdez-Silva FJ; St-Onge L; Gauthier BR
Nat Commun; 2018 Apr; 9(1):1488. PubMed ID: 29662071
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
Montolio M; Biarnés M; Téllez N; Escoriza J; Soler J; Montanya E
J Endocrinol; 2007 Jan; 192(1):169-77. PubMed ID: 17210754
[TBL] [Abstract][Full Text] [Related]
24. Non-traditional roles of complement in type 2 diabetes: Metabolism, insulin secretion and homeostasis.
King BC; Blom AM
Mol Immunol; 2017 Apr; 84():34-42. PubMed ID: 28012560
[TBL] [Abstract][Full Text] [Related]
25. Cellular immune response to GAD in type 1 diabetes with residual beta-cell function.
Fukui M; Nakamura N; Nakano K; Kondo M
Diabetes Care; 1999 Oct; 22(10):1758-9. PubMed ID: 10526760
[No Abstract] [Full Text] [Related]
26. [Cells of innate and adaptive immunity in type 2 diabetes and obesity].
Guzmán-Flores JM; López-Briones S
Gac Med Mex; 2012; 148(4):381-9. PubMed ID: 22976756
[TBL] [Abstract][Full Text] [Related]
27. Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation.
Brooks-Worrell B; Palmer JP
Clin Exp Immunol; 2012 Jan; 167(1):40-6. PubMed ID: 22132883
[TBL] [Abstract][Full Text] [Related]
28. Effects of renin-angiotensin system blockade on the islet morphology and function in rats with long-term high-fat diet.
Yuan L; Li X; Li J; Li HL; Cheng SS
Acta Diabetol; 2013 Aug; 50(4):479-88. PubMed ID: 20628770
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of M1-like macrophages in type 2 diabetic islets is followed by a systemic shift in macrophage polarization.
Cucak H; Grunnet LG; Rosendahl A
J Leukoc Biol; 2014 Jan; 95(1):149-60. PubMed ID: 24009176
[TBL] [Abstract][Full Text] [Related]
30. Distribution of IL-1β immunoreactive cells in pancreatic biopsies from living volunteers with new-onset type 1 diabetes: comparison with donors without diabetes and with longer duration of disease.
Reddy S; Krogvold L; Martin C; Holland R; Choi J; Woo H; Wu F; Dahl-Jørgensen K
Diabetologia; 2018 Jun; 61(6):1362-1373. PubMed ID: 29589071
[TBL] [Abstract][Full Text] [Related]
31. Opposing effects of IL-1β/COX-2/PGE2 pathway loop on islets in type 2 diabetes mellitus.
Wang G; Liang R; Liu T; Wang L; Zou J; Liu N; Liu Y; Cai X; Liu Y; Ding X; Zhang B; Wang Z; Wang S; Shen Z
Endocr J; 2019 Aug; 66(8):691-699. PubMed ID: 31105125
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors and NLRP3 as central regulators of pancreatic islet inflammation in type 2 diabetes.
Westwell-Roper C; Nackiewicz D; Dan M; Ehses JA
Immunol Cell Biol; 2014 Apr; 92(4):314-23. PubMed ID: 24492799
[TBL] [Abstract][Full Text] [Related]
33. The human serum protein C4b-binding protein inhibits pancreatic IAPP-induced inflammasome activation.
Kulak K; Westermark GT; Papac-Milicevic N; Renström E; Blom AM; King BC
Diabetologia; 2017 Aug; 60(8):1522-1533. PubMed ID: 28500395
[TBL] [Abstract][Full Text] [Related]
34. IL-20 contributes to low grade inflammation and weight gain in the Psammomys obesus.
Cucak H; Høj Thomsen L; Rosendahl A
Int Immunopharmacol; 2017 Apr; 45():53-67. PubMed ID: 28187313
[TBL] [Abstract][Full Text] [Related]
35. Islet inflammation in type 2 diabetes and physiology.
Eguchi K; Nagai R
J Clin Invest; 2017 Jan; 127(1):14-23. PubMed ID: 28045399
[TBL] [Abstract][Full Text] [Related]
36. Islet inflammation in type 2 diabetes.
Marchetti P
Diabetologia; 2016 Apr; 59(4):668-72. PubMed ID: 26894276
[No Abstract] [Full Text] [Related]
37. An Islet-Targeted Genome-Wide Association Scan Identifies Novel Genes Implicated in Cytokine-Mediated Islet Stress in Type 2 Diabetes.
Sharma PR; Mackey AJ; Dejene EA; Ramadan JW; Langefeld CD; Palmer ND; Taylor KD; Wagenknecht LE; Watanabe RM; Rich SS; Nunemaker CS
Endocrinology; 2015 Sep; 156(9):3147-56. PubMed ID: 26018251
[TBL] [Abstract][Full Text] [Related]
38. TLR4 is required for the obesity-induced pancreatic beta cell dysfunction.
Li J; Chen L; Zhang Y; Zhang WJ; Xu W; Qin Y; Xu J; Zou D
Acta Biochim Biophys Sin (Shanghai); 2013 Dec; 45(12):1030-8. PubMed ID: 23985305
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
40. Islet inflammation in type 2 diabetes: from metabolic stress to therapy.
Donath MY; Schumann DM; Faulenbach M; Ellingsgaard H; Perren A; Ehses JA
Diabetes Care; 2008 Feb; 31 Suppl 2():S161-4. PubMed ID: 18227479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
